Table 1.
Characteristics of Patients With S282T
| Characteristic | Overall (n = 10) |
|---|---|
| Age, years, mean (range) | 55 (34‐72) |
| Sex, n (%) | |
| Men | 8 (80) |
| Women | 2 (20) |
| Race, n (%) | |
| White | 8 (80) |
| Black | 2 (20) |
| Body mass index, kg/m2, mean (range) | 31 (22‐37) |
| Cirrhosis, n (%) | 5 (50) |
| IL28B non‐CC, n (%) | 8 (89)a |
| Mean baseline HCV RNA, log10 IU/mL (range) | 6.7 (6.0‐7.8)b |
| Genotype, n (%) | |
| GT1a | 4 (40) |
| GT1b | 1 (10) |
| GT2b | 1 (10) |
| GT3a | 1 (10) |
| GT4r | 1 (10) |
| GT5a | 1 (10) |
| GT6l | 1 (10) |
| Prior treatment status, n (%): | |
| Treatment‐naïve | 4 (40) |
| Treatment‐experienced, DAA‐naive | 1 (10) |
| DAA‐experienced | 5 (50) |
| Treatment, n (%) | |
| LDV/SOF | 8 (80) |
| SOF | 2 (20) |
a
Data were available for nine patients.
b
Based on data from eight patients.